PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21826704-11	2011	Chemical inhibition of JNK1/2 (SP600125) in MPD cells increased IGF-I expression (non-significantly), however, did not enhance differentiation.	pyrazolanthrone	31-39	insulin-like growth factor 1	Mus musculus	64-69	
19937471-3	2009	Inhibition of the MAPK pathway with SB203580, PD98059, or SP600125 significantly decreased IGF-I-induced AR phosphorylation and total AR protein expression.	pyrazolanthrone	58-66	insulin-like growth factor 1	Mus musculus	91-96	
19937471-4	2009	IGF-I-induced nuclear fraction of total AR and phosphorylated AR were significantly inhibited by SB203580, PD98059, or SP600125.	pyrazolanthrone	119-127	insulin-like growth factor 1	Mus musculus	0-5	
19937471-6	2009	Confocal images showed that IGF-I-induced AR nuclear translocation from cytosol was significantly blocked by SB203580, PD98059, or SP600125, suggesting that the MAPK pathway regulates IGF-I-induced AR nuclear localization in skeletal muscle cells.	pyrazolanthrone	131-139	insulin-like growth factor 1	Mus musculus	28-33	
19937471-6	2009	Confocal images showed that IGF-I-induced AR nuclear translocation from cytosol was significantly blocked by SB203580, PD98059, or SP600125, suggesting that the MAPK pathway regulates IGF-I-induced AR nuclear localization in skeletal muscle cells.	pyrazolanthrone	131-139	insulin-like growth factor 1	Mus musculus	184-189	
14963047-8	2004	A role for JNK in the survival of FL5.12 cells was supported by the observation that the JNK inhibitor SP600125 suppressed IGF-I-mediated protection from apoptosis.	pyrazolanthrone	103-111	insulin-like growth factor 1	Mus musculus	123-128